{"id":535394,"date":"2021-09-08T07:18:01","date_gmt":"2021-09-08T11:18:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/"},"modified":"2021-09-08T07:18:01","modified_gmt":"2021-09-08T11:18:01","slug":"vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/","title":{"rendered":"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary"},"content":{"rendered":"

\nBiopharma veteran enhances VectivBio\u2019s legal, regulatory and operational capabilities
\n<\/h2>\n
\n

BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (\u201cVectivBio\u201d) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the appointment of Scott Applebaum as Chief Legal Officer & Corporate Secretary. Mr. Applebaum brings over two decades of legal, regulatory and operational experience in the biopharmaceutical industry to VectivBio.<\/p>\n

\u201cScott has a great understanding of the legal and regulatory intricacies of the biotech and rare disease space,\u201d said Luca Santarelli, M.D., Founder and CEO of VectivBio.\u00a0\u201cHis knowledge and leadership will help guide us as we advance our Phase 3 trial of apraglutide in Short Bowel Syndrome with Intestinal Failure, pursue potential approval and expand our pipeline. Scott shares our passion for helping patients suffering from severe rare diseases and we are thrilled to have him join VectivBio.\u201d<\/p>\n

Scott Applebaum stated, \u201cThe VectivBio team is committed to developing innovative treatments to transform patients\u2019 lives. I am excited to return to the field of rare diseases and to join this top-notch team on this mission and look forward to helping the company achieve its goal of delivering medicines to those in need.\u201d<\/p>\n

Prior to joining VectivBio, Mr. Applebaum was the Chief Legal & Compliance Officer and Senior Vice President of Regulatory Affairs at Trevena, where he played a key role in gaining FDA approval for their lead product, Olinvyk\u00ae<\/em>. Previously, he served as President of Context Therapeutics and was General Counsel at Vitae Pharmaceuticals, where he was instrumental in their sale to Allergan. Formerly, he was Chief Legal Officer for Medgenics, a rare genetic disease company. Mr. Applebaum spent 10 years at Shire, where his roles included heading up their global legal group, managing their neuroscience portfolio outside of the United States as SVP of the Neuroscience Business Unit and leading the implementation and execution of the regulatory strategy for all of Shire\u2019s specialty pharmaceutical products worldwide as SVP of Global Regulatory Affairs, Quality Assurance and Compliance. Previously, he was Senior Counsel for medicines and medical imaging at Bristol Myers Squibb.<\/p>\n

Prior to his career in the biopharmaceutical industry, Mr. Applebaum was a lawyer at Dechert LLP. He received his J.D. from Stanford Law School and a B.S. in Economics, Finance and Accounting from the University of Pennsylvania.<\/p>\n

\n About VectivBio AG<\/strong>\n <\/p>\n

VectivBio (Nasdaq: VECT) is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. VectivBio is committed to pursuing product candidates with a clear mechanism of action and the potential to meaningfully transform and improve the lives of patients and their families. VectivBio\u2019s product candidate, apraglutide, is a next-generation GLP-2 analog being developed as a differentiated therapeutic for a range of rare gastrointestinal diseases. Apraglutide is currently being evaluated in a global Phase 3 clinical trial as a once-weekly treatment for short bowel syndrome with intestinal failure. VectivBio also plans to initiate clinical studies of apraglutide in additional indications, including graft versus host disease, where GLP-2 is believed to be central to disease pathophysiology.<\/p>\n

\n Forward Looking Statements<\/strong>\n <\/p>\n

Forward-looking statements are statements that are not historical facts. Words and phrases such as \u201canticipated,\u201d \u201cforward,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cmay,\u201d \u201cremain,\u201d \u201cpotential,\u201d \u201cprepare,\u201d \u201cexpected,\u201d \u201cbelieve,\u201d \u201cplan,\u201d \u201cnear future,\u201d \u201cbelief,\u201d \u201cguidance,\u201d and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties, many of which are difficult to predict and generally beyond VectivBio\u2019s control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. Such risks and uncertainties include, but are not limited to: the impacts of the ongoing COVID-19 pandemic and those risks and uncertainties identified in the \u201cRisk Factors\u201d section of VectivBio\u2019s Registration Statement on Form F-1 declared effective by the Securities and Exchange Commission on April 8, 2021 and its other subsequent filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, VectivBio undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.<\/p>\n

For more information visit\u00a0www.vectivbio.com<\/a><\/strong>, and follow us on\u00a0LinkedIn<\/strong><\/a> and Twitter<\/strong><\/a>.<\/p>\n

\n Investors<\/strong>
\n
Graham Morrell
graham.morrell@vectivbio.com<\/a><\/strong><\/p>\n

\n Media<\/strong>
\n
Morgan Warners
+1 (202) 295 0124
morgan.warners@fgh.com<\/a><\/strong><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Biopharma veteran enhances VectivBio\u2019s legal, regulatory and operational capabilities BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (\u201cVectivBio\u201d) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the appointment of Scott Applebaum as Chief Legal Officer & Corporate Secretary. Mr. Applebaum brings over two decades of legal, regulatory and operational experience in the biopharmaceutical industry to VectivBio. \u201cScott has a great understanding of the legal and regulatory intricacies of the biotech and rare disease space,\u201d said Luca Santarelli, M.D., Founder and CEO of VectivBio.\u00a0\u201cHis knowledge and leadership will help guide us as we advance our Phase 3 trial of apraglutide in Short Bowel Syndrome with Intestinal Failure, pursue potential approval … <\/p>\n

Continue reading “VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535394","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Biopharma veteran enhances VectivBio\u2019s legal, regulatory and operational capabilities BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (\u201cVectivBio\u201d) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the appointment of Scott Applebaum as Chief Legal Officer & Corporate Secretary. Mr. Applebaum brings over two decades of legal, regulatory and operational experience in the biopharmaceutical industry to VectivBio. \u201cScott has a great understanding of the legal and regulatory intricacies of the biotech and rare disease space,\u201d said Luca Santarelli, M.D., Founder and CEO of VectivBio.\u00a0\u201cHis knowledge and leadership will help guide us as we advance our Phase 3 trial of apraglutide in Short Bowel Syndrome with Intestinal Failure, pursue potential approval … Continue reading "VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T11:18:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary\",\"datePublished\":\"2021-09-08T11:18:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/\"},\"wordCount\":746,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/\",\"name\":\"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=\",\"datePublished\":\"2021-09-08T11:18:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/","og_locale":"en_US","og_type":"article","og_title":"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary - Market Newsdesk","og_description":"Biopharma veteran enhances VectivBio\u2019s legal, regulatory and operational capabilities BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (\u201cVectivBio\u201d) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the appointment of Scott Applebaum as Chief Legal Officer & Corporate Secretary. Mr. Applebaum brings over two decades of legal, regulatory and operational experience in the biopharmaceutical industry to VectivBio. \u201cScott has a great understanding of the legal and regulatory intricacies of the biotech and rare disease space,\u201d said Luca Santarelli, M.D., Founder and CEO of VectivBio.\u00a0\u201cHis knowledge and leadership will help guide us as we advance our Phase 3 trial of apraglutide in Short Bowel Syndrome with Intestinal Failure, pursue potential approval … Continue reading \"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T11:18:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary","datePublished":"2021-09-08T11:18:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/"},"wordCount":746,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/","name":"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=","datePublished":"2021-09-08T11:18:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTczMiM0MzkzNDQ1IzIyMDYxMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vectivbio-appoints-scott-applebaum-as-chief-legal-officer-corporate-secretary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535394"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}